Analysis of the effect of each clinicopathological feature on the prognosis of ovarian cancer revealed that there was a statistically significant effect of patient age, clinical stage, presence of ascites, CA125, HE4, and lymphatic metastasis on patient survival, while the effect of PTPRM expression on prognosis was not statistically significant, which may be due to the small sample size. This evidence concerns the gene WFDC2 and metastasis.